Filing Details

Accession Number:
0001209191-15-021263
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-03 16:26:04
Reporting Period:
2015-02-27
Filing Date:
2015-03-03
Accepted Time:
2015-03-03 16:26:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1488613 Foundation Medicine Inc. FMI Services-Medical Laboratories (8071) 271316416
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1585017 Jason Ryan 150 Second Street
C/O Foundation Medicine, Inc.
Cambridge MA 02141
Senior Vice President, Finance No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-02-27 2,750 $0.08 2,750 No 4 M Direct
Common Stock Acquisiton 2015-02-27 6,750 $0.84 9,500 No 4 M Direct
Common Stock Acquisiton 2015-02-27 10,750 $4.16 20,250 No 4 M Direct
Common Stock Acquisiton 2015-02-27 4,750 $7.12 25,000 No 4 M Direct
Common Stock Disposition 2015-02-27 25,000 $47.61 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2015-02-27 2,750 $0.00 2,750 $0.08
Common Stock Stock Option (right to buy) Disposition 2015-02-27 6,750 $0.00 6,750 $0.84
Common Stock Stock Option (right to buy) Disposition 2015-02-27 10,750 $0.00 10,750 $4.16
Common Stock Stock Option (right to buy) Disposition 2015-02-27 4,750 $0.00 4,750 $7.12
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,038 2021-06-15 No 4 M Direct
3,250 2022-03-27 No 4 M Direct
14,250 2023-03-07 No 4 M Direct
20,250 2023-05-21 No 4 M Direct
Footnotes
  1. The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.48 to $47.95, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
  2. This option was granted on June 15, 2011. Twenty-five percent vested on May 16, 2012 and an additional 6.25% vests each successive quarter thereafter until fully vested on May 16, 2015.
  3. This option was granted on March 27, 2012 and vests in equal quarterly installments over a four-year period beginning on June 27, 2012.
  4. This option was granted on March 7, 2013 and vests in equal quarterly installments over a four-year period beginning on June 7, 2013.
  5. This option was granted on May 21, 2013 and vests in equal quarterly installments over a four-year period beginning on April 1, 2014.